Editor Profiles

Dr. Aaron Lisberg is a hematologist and medical oncologist who is an Assistant Professor of Medicine at The University of California, Los Angeles. He specializes in the emerging field of immunotherapy, with a specific focus on malignancies of the lung. He is board certified in internal medicine, hematology and medical oncology. In addition to his clinical work, Dr. Lisberg conducts research on immunotherapy, and factors that might predict either a response or toxicity to immune checkpoint inhibition in lung cancer. He also conducts research on the synergistic nature of radiation and immune-based therapies. Dr. Lisberg received his medical degree from the University of Minnesota Medical School, where he was elected to the AOA honor society. He then completed his internal medicine residency at The University of Washington in Seattle, followed by his hematology/oncology fellowship at UCLA. He grew up in Minneapolis, Minnesota, and received his Bachelor of Arts degree in biology from Grinnell College. Research Interest: Immunotherapy, Oncology, Lung Cancer